Primoris International is a Cell Bio Innovation Company built on 30 years of stem cell research. Driven by bold innovation and advanced biotechnology, it is a leader in the exosome market. The company holds international patents for its proprietary stem cell technology and has published over 290 papers in international scientific journals, showcasing its world-class competitiveness. Leveraging its exosome expertise, it continues to pioneer a wide range of sectors, from raw materials to cosmetics